Sign in

CIK 0000315545

  • Non-accelerated filer
  • Smaller reporting company

PROVECTUS BIOPHARMACEUTICALS, INC.

Sign in to watch
Ticker
PVCT
Exchange
OTC
Industry
Pharmaceutical Preparations
FY end
Dec 31
Incorporated
DE
Entity type
Operating
EIN
900031917
Phone
+1 866-594-5999
Business address
800 S. GAY STREET, SUITE 1610, KNOXVILLE, TN, 37929
Former names
PROVECTUS PHARMACEUTICALS INC, PROVECTUS PHARMACEUTICAL INC, ZAMAGE DIGITAL IMAGING INC, SPM GROUP INC
Open-market buys, last 90 days
$0
in 0 filings
Open-market sales, last 90 days
$0
in 0 filings

Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.

Reading 100 more Form 4s from the SEC; this list fills in as they're read.

Date Insider Transaction Shares Price Value Owned after
2023-11-29 Pershing Edward Director Grant or award · 8% Unsecured Convertible Promissory Note +0 $50,000.00 $0
2023-11-15 Pershing Edward Director Option exercise · 8% Unsecured Convertible Promissory Note −0
2023-11-15 Pershing Edward Director Option exercise · Series D-1 Convertible Preferred Stock +9,440 772,920
2023-11-08 Pershing Edward Director Option exercise · 8% Unsecured Convertible Promissory Note −0
2023-11-08 Pershing Edward Director Option exercise · Series D-1 Convertible Preferred Stock +37,744 763,480
2023-11-01 Pershing Edward Director Option exercise · 8% Unsecured Convertible Promissory Note −0
2023-11-01 Pershing Edward Director Option exercise · Series D-1 Convertible Preferred Stock +13,216 725,736
2023-10-27 Pershing Edward Director Option exercise · 8% Unsecured Convertible Promissory Note −0
2023-10-27 Pershing Edward Director Option exercise · Series D-1 Convertible Preferred Stock +2,832 712,520
2023-10-14 Pershing Edward Director Option exercise · 8% Unsecured Convertible Promissory Note −0
2023-10-14 Pershing Edward Director Option exercise · Series D-1 Convertible Preferred Stock +18,888 709,688
2023-10-03 Pershing Edward Director Purchase · Series D-1 Convertible Preferred Stock +19,311 $2.86 $55K 690,800
2023-09-30 Pershing Edward Director Option exercise · 8% Unsecured Convertible Promissory Note −0
2023-09-30 Pershing Edward Director Option exercise · Series D-1 Convertible Preferred Stock +41,518 671,489
2023-09-23 Pershing Edward Director Option exercise · 8% Unsecured Convertible Promissory Note −0
2023-09-23 Pershing Edward Director Option exercise · Series D-1 Convertible Preferred Stock +28,320 629,971
2023-09-01 Pershing Edward Director Option exercise · 8% Unsecured Convertible Promissory Note −0
2023-09-01 Pershing Edward Director Option exercise · Series D-1 Convertible Preferred Stock +37,760 601,651
2023-08-11 Morris Jeffrey Allen 10% owner Grant or award · 8% Secured Convertible Promissory Note +0 244,584
2023-08-03 Pershing Edward Director Grant or award · 8% Unsecured Convertible Promissory Note +0 $75,000.00 $0

Page 10 of 17 · 329 trades